Skip to main content

Table 2 CV outcomes categories

From: Baseline diabetes as a way to predict CV outcomes in a lipid-modifying trial: a meta-analysis of 330,376 patients from 47 landmark studies

Total mortality all-cause death A
Composite all CV events (including procedures) B
  MACE C
  CV death D
Cardiac total CHD/major coronary events E
  nonfatal CHD F
  cardiac death/fatal CHD G
  ACS/ACE H
  all MI I
  nonfatal MI J
  fatal MI K
  unstable/hospitalization-requiring AP L
  coronary revascularization (PCI or CABG) M
  life-threatening arrhytmias N
  resuscitation for cardiac arrest O
  sudden death P
  CHF Q
Coronary imaging angiographic CAD progression/change in coronary atheroma volume R
Cerebrovascular all major cerebrovascular events S
  all stroke/TIA T
  nonfatal stroke U
  fatal stroke V
  carotid revascularization W
Other composite non-CHD MACE X
Other mortality non-CHD CV death Y
Peripheral any PAD event (including revascularization and leg amputation) Z
  1. ACE/ACS: acute coronary event/syndrome; AP angina pectoris; CABG: coronary artery bypass graft; CAD: coronary artery disease; CHD: coronary heart disease; CHF: congestive heart failure; CV: cardiovascular; MACE: major adverse cardiovascular event; MI myocardial infraction; PAD: peripheral arterial disease; PCI: percutaneous coronary intervention; TIA:transient is chemic attack (adapted from [91])